logo

5.42

5.42 (0.75%)

As of Mar 06, 2024

Savara Inc [SVRA]

Source: 

Company Overview

Savara Inc. (together with its subsidiaries Savara, the Company, we, our or us) is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution (molgramostim, formerly referred to as Molgradex), is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

CountryUnited States
Headquartersaustintexas
Phone Number51285113796
Industry
manufacturing
CEOMatthew Pauls
Websitehttp://www.savarapharma.com